Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Neal, Gabriel A
NCT06219720: The Texas Interprofessional Pharmacogenomics (IPGx)	Recruiting	N/A	50	US		Texas A&M University, InnovativeGx, Texas A&M Health Family Care Clinic, iC42 Clinical Research and Development, Goldblatt systems	Adverse Drug Reaction	11/26	11/27
NCT06766071: IPGx PILOT Whole Genome Sequencing Extension Cohort	Recruiting	N/A	50	US		Texas A&M University	Adverse Drug Reaction (ADR), Polypharmacy Patients	01/26	01/26
IPGx Registry, NCT06726590: Interprofessional Pharmacogenomics (IPGx) Registry and Repository	Recruiting	N/A	3000	US		Texas A&M University	Diabetes, Cholesterol, Cancer, Blood Pressure Disorders, Heart Disease, Respiratory Ilness, COPD, Adverse Drug Reaction (ADR), Poly Pharmacy	11/29	11/29
Rogers, Sara
NCT06219720: The Texas Interprofessional Pharmacogenomics (IPGx)	Recruiting	N/A	50	US		Texas A&M University, InnovativeGx, Texas A&M Health Family Care Clinic, iC42 Clinical Research and Development, Goldblatt systems	Adverse Drug Reaction	11/26	11/27
NCT06766071: IPGx PILOT Whole Genome Sequencing Extension Cohort	Recruiting	N/A	50	US		Texas A&M University	Adverse Drug Reaction (ADR), Polypharmacy Patients	01/26	01/26
IPGx Registry, NCT06726590: Interprofessional Pharmacogenomics (IPGx) Registry and Repository	Recruiting	N/A	3000	US		Texas A&M University	Diabetes, Cholesterol, Cancer, Blood Pressure Disorders, Heart Disease, Respiratory Ilness, COPD, Adverse Drug Reaction (ADR), Poly Pharmacy	11/29	11/29